Clinical Trial Update: REKinDLE: Registry With Enbrel® or Kineret® in a Database Using Longitudinal Evaluations

View source ↗

Summary

Clinical trial update for the REKinDLE registry, comparing Enbrel (etanercept) and Kineret (anakinra) in rheumatoid arthritis; the study status is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rheumatoid Arthritis

Drugs mentioned

• ENBREL (etanercept)
• KINERET (ANAKINRA)

Snippet

Sponsor: Amgen | Conditions: Rheumatoid Arthritis | Status: COMPLETED